Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

World's most in-depth study to detect early signs of Alzheimer's disease

Clinical Trials Research

A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer's disease ever performed on volunteers, is announced today (Monday 22 August).

Brain structure may be root of apathy © Alex Mit - Shutterstock

Image courtesy of Shutterstock

The Deep and Frequent Phenotyping study is funded by the National Institute of Health Research and the MRC and hopes to dramatically improve the success rate of clinical trials for treatments in Alzheimer's disease.

This landmark £6.9million research project has been designed to identify measurable characteristics, known as biomarkers, which can detect the occurrence of Alzheimer's disease very early on in the progression of the disease - when a person may have no obvious symptoms.

Read more